303 related articles for article (PubMed ID: 25151306)
1. Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via inhibition of AMPK and activation of p38 MAPK signaling.
Wang J; Liu Z; Feng X; Gao S; Xu S; Liu P
Arch Biochem Biophys; 2014 Nov; 562():22-30. PubMed ID: 25151306
[TBL] [Abstract][Full Text] [Related]
2. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
[TBL] [Abstract][Full Text] [Related]
3. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
4. Endogenous BNP attenuates cardiomyocyte hypertrophy induced by Ang II via p38 MAPK/Smad signaling.
Chen Y; Yao F; Chen S; Huang H; Wu L; He J; Dong Y
Pharmazie; 2014 Nov; 69(11):833-7. PubMed ID: 25985580
[TBL] [Abstract][Full Text] [Related]
5. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
[TBL] [Abstract][Full Text] [Related]
6. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
7. Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway.
Li XX; Zhang P; Yang Y; Wang JJ; Zheng YJ; Tan JL; Liu SY; Yan YM; Zhang YY; Cheng YX; Yang HT
Acta Pharmacol Sin; 2022 Mar; 43(3):588-601. PubMed ID: 33967278
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
9. Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy.
Slone S; Anthony SR; Wu X; Benoit JB; Aube J; Xu L; Tranter M
Cell Signal; 2016 Nov; 28(11):1735-41. PubMed ID: 27521603
[TBL] [Abstract][Full Text] [Related]
10. Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway.
Wang S; Han HM; Pan ZW; Hang PZ; Sun LH; Jiang YN; Song HX; Du ZM; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):823-31. PubMed ID: 22569796
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
Ye Y; Mou Y; Bai B; Li L; Chen GP; Hu SJ
Int J Biochem Cell Biol; 2010 Dec; 42(12):2056-64. PubMed ID: 20884373
[TBL] [Abstract][Full Text] [Related]
12. MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo.
Degousee N; Martindale J; Stefanski E; Cieslak M; Lindsay TF; Fish JE; Marsden PA; Thuerauf DJ; Glembotski CC; Rubin BB
Circ Res; 2003 Apr; 92(7):757-64. PubMed ID: 12649265
[TBL] [Abstract][Full Text] [Related]
13. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase.
Stuck BJ; Lenski M; Böhm M; Laufs U
J Biol Chem; 2008 Nov; 283(47):32562-9. PubMed ID: 18790741
[TBL] [Abstract][Full Text] [Related]
14. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W
Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424
[TBL] [Abstract][Full Text] [Related]
15. Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.
Li Y; Zhang D; Kong L; Shi H; Tian X; Gao L; Liu Y; Wu L; Du B; Huang Z; Liang C; Wang Z; Yao R; Zhang Y
Exp Cell Res; 2018 Sep; 370(1):78-86. PubMed ID: 29902536
[TBL] [Abstract][Full Text] [Related]
16. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
Li RL; Wu SS; Wu Y; Wang XX; Chen HY; Xin JJ; Li H; Lan J; Xue KY; Li X; Zhuo CL; Cai YY; He JH; Zhang HY; Tang CS; Wang W; Jiang W
J Mol Cell Cardiol; 2018 Aug; 121():242-255. PubMed ID: 30053525
[TBL] [Abstract][Full Text] [Related]
17. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
18. CMTM3 deficiency induces cardiac hypertrophy by regulating MAPK/ERK signaling.
Ye J; Yan S; Liu R; Weng L; Jia B; Jia S; Xiong Y; Zhou Y; Leng M; Zhao J; Yang F; Zheng M
Biochem Biophys Res Commun; 2023 Jul; 667():162-169. PubMed ID: 37229825
[TBL] [Abstract][Full Text] [Related]
19. Adenosine 5'-monophosphate-activated protein kinase and p38 mitogen-activated protein kinase participate in the stimulation of glucose uptake by dinitrophenol in adult cardiomyocytes.
Pelletier A; Joly E; Prentki M; Coderre L
Endocrinology; 2005 May; 146(5):2285-94. PubMed ID: 15677757
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
